NCT02492581View on ClinicalTrials.gov

Use of Selincro and Impact on Usual Practice

CompletedOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Alcohol Dependence
Interventions
DRUG

Nalmefene

No intervention on the use of Selincro. The physician will prescribe Selincro following its usual practice.

Trial Locations (1)

33076

University of Bordeaux, Bordeaux

All Listed Sponsors
collaborator

Lundbeck France

UNKNOWN

lead

University of Bordeaux

OTHER

NCT02492581 - Use of Selincro and Impact on Usual Practice | Biotech Hunter | Biotech Hunter